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May Supplement 200936S Poster Presentationsage was 68 (interquartile range 58-74) and 539 (37%) were female. We used
multiple logistic regression to evaluate preoperative risk factors for mortality
and neurologic deficit.
Results: Immediate neurologic deficit occurred postoperatively in
37/1443 (2.5%) of patients. Significant predictors were extent II aneurysm
and decreasing preoperative glomerular filtration rate (GFR). Use of cere-
brospinal fluid drainage and distal aortic perfusion (adjunct) reduced neu-
rologic morbidity by two thirds (odds ratio 0.33, p0.002). For mortality,
significant predictors were decreased GFR, preoperative rupture, peripheral
vascular disease, coronary artery disease and extent 2 or 3 aneurysm. With
normal GFR ( 90 ml/min 1.73 m2), mortality was 6%.
Conclusion: Use of the adjunct cerebrospinal fluid drainage and distal
aortic perfusion has had a major impact on spinal cord morbidity. The
greatest mortality occurs in patients with multiple preoperative risk factors,
with treatment playing a secondary role. Patients with good preoperative
renal function have low morbidity and mortality.
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Background: Acute aortic syndromes are life threatening. Time is of
the essence as mortality rises with increasing time after the acute episode.
The keys to successful treatment of acute aortic disease include early diag-
nosis, transfer to the appropriate care facility, rapid institution of therapy,
availability of cardiovascular anesthesia, and dedicated cardiovascular inten-
sive care unit care.
Objective: To report the outcomes of a pathway, an Acute Aortic
Treatment Center (AATC), to expedite the care of acute aortic syndromes in
a major metropolitan area with the hypothesis that “door to intervention”
time under 90 minutes reduces mortality and morbidity from acute aortic
disease.
Methods: A database of patients admitted with aortic disease during
one year prior to initiation (2007) and one year after initiation of AATC in
2008 was developed. Anatomic and functional outcomes were determined
and categorized by Society of Vascular Surgery reporting criteria. Multivar-
iate analysis and Cox proportional hazard analyses were performed.
Results: A Total of 621 patients reported with aortic disease to the
cardiovascular services; 304 patients were admitted of which 73(25%) were
considered to have acute disease. When compared to the year before the
AATC there was a 10 % increase in total number of admissions and a 25 %
increase in acute pathology after setting up the AATC (p0.02). There was
a 2 fold increase in thoracic aortic dissections admitted to the service.
Initiation of AATC resulted in significant reduction in time to definitive
therapy (61% decrease) (p0.016). Despite the increase in acuity, mortality
and morbidity rates were unchanged and there were trends to lower ICU
and total hospital stay (Table).
Conclusion: Institution of AATC increased awareness for correct and
early diagnosis of the acute aorta, reduced time to definitive treatment,
increased referrals and appeared to impact inpatient hospital stays. Wide-
spread adoption of the AATC paradigm is recommended.
Table
Variable Pre- AATC AATC p-value
Total Inpatients - n (%) 130 161
Acute Presentations - n (%) 24(18) 49(30) 0.02
Time to Definite Acute Care -
mean  SD (median) min
328363 (107) 129156 (73) 0.015
Mortality - n (%) 1(4) 5(10) 0.66
Morbidity - n (%) 19(79) 33(67) 0.41
LOS ICU - mean  SD days 1114 98 0.52
LOS Hospital - mean  SD days 2120 159 0.17
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Objectives: The incidence and risk of renal failure after thoracic
endovascular aortic repair (TEVAR) has not been well established. The aim
of this study was to assess the incidence of renal failure after TEVAR and to
determine associated risk factors.
Methods: Between 1998 and 2008, 175 consecutive patients under-
went 210 TEVAR procedures for various aortic pathologies at two tertiary
academic institutions. Similar imaging protocols such as intravascular ultra-
sound (IVUS) and nephro-protective measures were used. Retrospective
analysis of prospectively collected data was performed. Linear regression
analysis was performed to identify factors (p0.05) associated with a de-
crease in estimated glomerular filtration rate (eGFR) based on the RIFLE
criteria.
Results: The patient’s underlying aortic pathologies included: 103
aneurysms, 72 dissections, 21 transections, and 14 penetrating ulcers.
Median age was 70 years (interquartile range (IQR): 58-78). Median
preoperative eGFR was 65 mL/min/1.73m2 (IQR 47-86). Average proce-
dural contrast was 108.769.8mL (IQR: 60-150). Median eGFR at 24 hrs,
and 30 days were 69mL/min/1.73m2 (IQR: 46-95) and 67mL/min/
1.73m2 (IQR: 48-88), respectively. The rate of acute renal injury, acute
renal failure, and hemodialysis was 13.7% (27/197), 3.1% (6/197) and 0.5%
(1/197), respectively. At one month, the rate of worsening renal function
from baseline was 13.3% (10/75), while at 6 months it was 17.7% (6/34).
No additional patients went on hemodialysis in follow-up. Risk factors
associated with decrease in eGFR at 24 hrs were procedural blood loss,
packed red blood cells transfusion, lengthy procedures, open surgical con-
version and number of deployed stent grafts. At one month, prognostic
factors included increasing age, preoperative leaking aortic pathologies,
concomitant abdominal aortic aneurysm, zone 0-2 deployment, larger prox-
imal neck diameter, and shorter ICU and hospital stay. Nephro-protective
factors were obesity, trauma as underlying pathology, preoperative meta-
stable hemodynamics and perioperative deep venous thrombosis.
Conclusion: The incidence of renal failure in this cohort was lower
compared to previous smaller series. Routine use of IVUS, and significantly
reduced contrast use may contribute to lower rate of renal failure in early
follow-up.
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Herzzentrum Berlin, Berlin, Germany
Background: Patients with descending thoracic aneurysm (DTA) re-
pair after previous abdominal aortic aneurysm (AAA) surgery have a high risk
for spinal cord ischemia and renal dysfunction. This study evaluates the
outcome after thoracic endograft implantation and conventional descending
aneurysm surgery in patients with prior AAA repair.
Methods: Retrospectively, 63 patients with previous AAA repair were
identified. In 29 patients thoracic endograft was implanted (8 emergency).
Twenty-one patients had DTA and 8 patients type B dissection. In the
surgical group we included 20 patients with descending aortic replacement
above the diaphragm comparable with the endovascular group. There were
10 emergency procedures. Two patients had type B dissection and 18
patients DTA.
Results: The mean time interval between prior AAA repair and subse-
quent thoracic procedure was 5.5 years (125 days to 17 years) for endograft
and 5.7 years (16 days to 13 years) for surgical repair. Endograft placement
was successful in all patients. In 5 patients the left subclavian artery was
occluded. The 30-day mortality was 6.8% (2/29 pts.) in the endovascular
group and 15% (3/20 pts.) in the surgical group. The rate of postoperative
neurological complications differed but without statistical significance,
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ing hemodialysis differed significantly between the groups (Table).
Conclusions: Endograft implantation in patients with descending
thoracic aneurysm after previous abdominal aortic surgery can be performed
without technical problems. In comparison to patients with conventional
repair, those with endograft implantation have a statistically significantly
lower risk of renal failure and shorter intubation time with less blood
transfusion. Although no statistical difference is present, the early outcome
of endovascular graft treatment appears to be better than that of conven-
tional surgical repair, also in respect to neurological complications and
mortality. Statistical analysis of results in endovascular group and surgical
group.
Variables
Endovascular
group (n29)
Surgical
group
(n20) P value
Age (meanSD) 716.4 696.4 n.s.
Sex(male/female) 24/5 16/4 n.s.
Creatinine (mg/dl) 1.571.4 1.420.5 n.s.
Preop.(meanSD)Postop.
(meanSD)
1.921.7 2.31.2 0.04
Postop. dialyses (n) 1 (3.4%) 6 (30%) 0.02
Neurological complications (n) 2 (6.8%) 3 (15%) n.s.
Intubation time (hours)
(median) (range)
6 (3-720) 60 (24-1560) 0.001
Blood transfusion (ml)
(meanSD)
(249456) (21261809) 0.01
Secondary thoracotomy (n) 1 (3.4%) 3 (15%) n.s.
30-day mortality (n) 2 (6.8%) 3 (15%) n.s.
Author Disclosures: S. Buz,None;B. Zipfel,None;B. Tutkun,None;R.
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A Novel Approach
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Thomas C Bower, Manju Kalra, Audra A Duncan, Peter Gloviczki. Mayo
Clinic, Rochester, MN
Objective: Controlled hypotension is critical for precise deployment of
endografts in the thoracic aorta and for safe balloon dilation after deploy-
ment. Rapid right ventricular pacing (RRVP) via a transfemoral venous
catheter has been reported previously as a technique to facilitate thoracic
endograft placement. We describe a novel approach to RRVP using a
pulmonary artery catheter (PAC) that is placed during the endograft proce-
dure for hemodynamic monitoring.
Methods:Clinical and radiological records of 12 patients (8 men and 4
women, mean age 80 years, range 75 - 89) who underwent endograft
placement in the thoracic aorta with PAC- directed RRVP were reviewed.
Endografts were placed to treat thoracic aneurysms (mean size 65 8 mm)
in 10 patients, and penetrating aortic ulcers in 2 patients. All endografts but
one were deployed in the proximal aorta (zones 1-3). Hemodynamic param-
eters, accuracy of deployment, complications related to RRVP and PAC
placement, presence of endoleaks and postoperative complications were
evaluated.
Results: PAC-directed RRVPwas performed during endograft deploy-
ment and post-deployment balloon dilation without technical difficulty or
delayed recovery in all patients. A median of two pacing episodes were
performed for each patient (range 1-4). The length of each pacing episode
was less than 15 seconds (mean 11 seconds, range 6-14). Mean pacing rate
was 165  15 beats per minute which achieved an average mean arterial
pressure of 42 8 mm Hg for a mean duration of 16 seconds. After pacing
cessation, the recovery time of mean arterial pressure from 428 mmHg to
pre-pacing levels was within 8 seconds in all patients. All endografts were
deployed with precise positioning at amean of 2.52mm from the intended
placement site. No complications related to RRVP or PAC placement
occurred. No type I endoleaks nor postoperative complications were ob-
served. There was no peri-operative mortality.
Conclusion: PAC-directed RRVP is a safe and effective method of
inducing hypotension, enabling precise thoracic endograft deployment and
safe balloon dilation after deployment. It avoids the use of femoral venous
access and its associated potential complications, and obviates the need to
involve a cardiologist, simplifying the procedure and utilizing resources
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Kingdom
Objective: Open repair of descending thoracoabdominal aneurysms
(TAA) is associated with significant mortality and morbidity. We assessed the
impact of surgical adjuncts on outcomes for patients undergoing open TAA
repair.
Methods: Retrospective analysis of a prospectively maintained data-
base was performed to assess the impact of adjunctive techniques on out-
comes for patients undergoing elective TAA repair (Crawford type I-IV)
between January 1992 and January 2008. Patients were divided into two
groups based on the period of operation: group A (1992-2000) and group
B (2000-2008). Surgical adjuncts were introduced for patients in group B
(CSF drainage for all; distal aortic perfusion and selective visceral perfusion
for type I, II and III aneurysms only; a cell saver for type IV).
Results: A consecutive series of 109 patients with a median age of 69
years (range 21-89) were analysed. The mean operating time for group A
(n31) was 195 minutes (range 140-480) compared with 200 minutes
(range 90-300) in group B (n78). Median blood loss for group A was
3682 ml (range 2495-10000) compared with 3000 ml (range 400-17000)
for group B. The combined mortality rate was 32.2% in group A (type I-III,
25.0%; type IV, 37.4%) compared with 14.1% in group B (type I-III, 17.1%;
type IV, 10.8%;p0.03).The overall complication rate in group Awas 61.3%
(type I-III, 50.0%; type IV, 68.8%) compared with 37.1% in group B (type
I-III, 48.8%; type IV, 21.6%; p0.02). The overall paraplegia rate was 12.9%
in group A (type I-III, 18.8%; type IV, 6.3%) compared with 7.7% in group
B type I-III, 14.6%; type IV, 0%).
Conclusions: Series from individual specialist centres report excellent
outcomes after TAA repair but this is in contrast with multi-centre data. The
introduction of adjunctive techniques in our series has resulted in a reduc-
tion inmortality and complication rates but they remain high.Monitoring of
spinal cord function may reduce the rate of paraplegia.
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Objective: To discuss the causation and prevention of the stent-graft-
induced new entry (SINE) following endovascular aortic repair (EVAR) for
type B dissection.
Methods: SINE was defined as the new tear caused by the stent-graft
itself, excluding those created by the injury from any inappropriate endovas-
cular manipulation. Twenty one paitents with SINE were retrospectively
collected and analysed out of 650 cases undergoing EVAR for type B
dissection from August 2000 to June 2008 in our center.
Results: Totally, there were 22 SINEs found in 21cases. SINE oc-
curred at the proximal end of the endograft in 15 cases, at the distal in 5, and
at both in 1. Its incidence was 3.2% and onset time varied from post-
operative 2 hours to 60 months (mean 915 months). All 16 proximal
SINEs lead to retrograde type A dissection. Two distal SINEs caused
enlarging aneurysm and 4 remained stable. Devices used and management
are shown in the Table. Devices Used and Management of SINEs SINE
indicates the stent-graft-induced new entry. Six patients died and the mor-
tality reached 29%. All 21 cases had the endograft placed across the distal
aortic arch. Thirteen proximal SINEs were evidenced at the greater curve of
the arch, and all distal SINEs at the dissection flap.
